IFP Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.61M Sell
5,215
-76
-1% -$36.5K 0.05% 411
2026
Q1
$2.6M Sell
5,291
-42
-0.8% -$22.8K 0.05% 379
2025
Q4
$3.09M Buy
5,333
+1
+0% +$566 0.07% 312
2025
Q3
$2.59M Sell
5,332
-250
-4% -$116K 0.07% 319
2025
Q2
$2.38M Sell
5,582
-331
-6% -$138K 0.07% 322
2025
Q1
$2.94M Sell
5,913
-1,595
-21% -$864K 0.09% 260
2024
Q4
$3.91M Buy
7,508
+1,178
+19% +$648K 0.13% 173
2024
Q3
$3.92M Buy
6,330
+160
+3% +$94.7K 0.14% 154
2024
Q2
$3.41M Sell
6,170
-32
-0.5% -$18.3K 0.14% 154
2024
Q1
$3.61M Sell
6,202
-177
-3% -$99.3K 0.16% 140
2023
Q4
$3.39M Sell
6,379
-220
-3% -$106K 0.16% 142
2023
Q3
$3.34M Sell
6,599
-3,236
-33% -$1.72M 0.15% 132
2023
Q2
$5.13M Sell
9,835
-4,907
-33% -$2.65M 0.21% 95
2023
Q1
$1.93M Sell
14,742
-2,493
-14% -$1.41M 0.08% 240
2022
Q4
$2.44M Sell
17,235
-1,596
-8% -$846K 0.07% 327
2022
Q3
$2.93M Buy
18,831
+1,483
+9% +$830K 0.08% 285
2022
Q2
$2.72M Hold
17,348
0.09% 269
2022
Q1
$2.72M Buy
17,348
+4,987
+40% +$2.86M 0.09% 269
2021
Q4
$8.24M Buy
12,361
+1,134
+10% +$708K 0.16% 75
2021
Q3
$6.41M Buy
11,227
+108
+1% +$59.3K 0.13% 90
2021
Q2
$5.66M Buy
11,119
+439
+4% +$207K 0.12% 97
2021
Q1
$4.87M Sell
10,680
-929
-8% -$443K 0.09% 100
2020
Q4
$5.39M Buy
11,609
+11
+0.1% +$5.16K 0.22% 77
2020
Q3
$5.12M Buy
11,598
+527
+5% +$218K 0.31% 64
2020
Q2
$3.89M Buy
11,071
+1,548
+16% +$519K 0.31% 70
2020
Q1
$2.7M Buy
9,523
+1,115
+13% +$352K 0.27% 81
2019
Q4
$2.75M Buy
8,408
+2,523
+43% +$765K 0.21% 115
2019
Q3
$1.68M Buy
+5,885
New +$1.69M 0.11% 208
2019
Q1
$232K Sell
845
-11,017
-93% -$2.74M 0.03% 433
2018
Q4
$2.64M Sell
11,862
-1,763
-13% -$414K 0.16% 147
2018
Q3
$3.33M Sell
13,625
-325
-2% -$74.8K 0.14% 174
2018
Q2
$2.89M Buy
13,950
+144
+1% +$30.6K 0.12% 188
2018
Q1
$2.62M Hold
13,806
0.12% 198
2017
Q4
$2.62M Sell
13,806
-825
-6% -$158K 0.12% 199
2017
Q3
$2.77M Sell
14,631
-771
-5% -$140K 0.11% 202
2017
Q2
$2.69M Buy
15,402
+479
+3% +$80.5K 0.11% 204
2017
Q1
$2.29M Sell
14,923
-804
-5% -$123K 0.1% 221
2016
Q4
$2.22M Buy
15,727
+4,080
+35% +$602K 0.11% 209
2016
Q3
$1.85M Sell
11,647
-66
-0.6% -$10.2K 0.1% 238
2016
Q2
$1.73M Buy
11,713
+10,868
+1,286% +$1.6M 0.1% 240
2016
Q1
$232K Sell
845
-7,311
-90% -$980K 0.03% 433
2015
Q4
$1.16M Buy
+8,156
New +$1.09M 0.08% 274

Other funds holding TMO

IFP Advisors's TMO Position: Q2 2026 in Review

IFP Advisors reduced its Thermo Fisher Scientific (TMO) stake by 1.4% in Q2 2026, selling an estimated $36.5K and leaving 5,215 shares worth $2.61M. The position accounts for 0.05% of the portfolio, ranked #411.

IFP Advisors first reported a position in TMO in Q4 2015 and has held it in 42 quarters since. The position peaked at $8.24M in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • IFP Advisors held 5,215 shares of Thermo Fisher Scientific worth $2.61M as of Q2 2026.
  • IFP Advisors sold 76 Thermo Fisher Scientific shares in Q2 2026, an estimated $36.5K.
  • Thermo Fisher Scientific made up 0.05% of IFP Advisors's portfolio in Q2 2026, its #411 holding.
  • IFP Advisors first reported a position in Thermo Fisher Scientific in Q4 2015 and has held it in 42 quarters since.
  • IFP Advisors's Thermo Fisher Scientific position peaked at $8.24M in Q4 2021.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.